Objectives To determine if confirmation of hypolactasia offers any benefit
to the dietary treatment of patients with irritable bowel syndrome (IBS).
Methods One hundred and twenty-two consecutive IBS patients (37 male, 85 fe
male) were given lactose hydrogen breath tests (LHBT). Those with positive
LHBT followed a low lactose diet for 3 weeks. Those improving on the diet w
ere given double-blind, placebo-controlled challenges (DBPCC) with 5 g, 10
g and 15 g of lactose and a placebo, to confirm lactose intolerance. Those
who did not respond to the low lactose diet followed either an exclusion or
low fibre diet. Symptoms scores were kept prior to the LHBT, 8 h post-LHBT
and daily whilst following any dietary change. Patients with negative LHBT
returned to clinic and subsequent dietary interventions were recorded.
Results LHBT was positive in 33/122 (27%) IBS patients. Symptom scores prio
r to LHBT were not significantly different between the two groups, but afte
r LHBT the symptoms in the positive group were significantly worse. Twenty-
three patients followed a low-lactose diet of which only nine (39%) improve
d. Six who did not improve followed an exclusion diet, three improved and a
ll were intolerant of milk. Three tried a low fibre diet with two improving
. DBPCC were inconclusive. In the negative LHBT group 35 agreed to try a di
et and 24 improved (69%). Eight were intolerant of cow's milk.
Conclusions Use of a low lactose diet was disappointing in IBS patients wit
h lactose malabsorption. Food intolerance was demonstrated in IBS patients
with positive or negative LHBT and milk was identified as a problem in both
groups. DBPCC were inconclusive. There appears to be little advantage in t
rying to separate patients who malabsorb lactose from others with IBS. Eur
J Gastroenterol Hepatol 13:219-225 (C) 2001 Lippincott Williams & Wilkins.